WO1995010044B1 - A method and apparatus for detecting hemolysis in a fluid sample - Google Patents

A method and apparatus for detecting hemolysis in a fluid sample

Info

Publication number
WO1995010044B1
WO1995010044B1 PCT/US1994/010588 US9410588W WO9510044B1 WO 1995010044 B1 WO1995010044 B1 WO 1995010044B1 US 9410588 W US9410588 W US 9410588W WO 9510044 B1 WO9510044 B1 WO 9510044B1
Authority
WO
WIPO (PCT)
Prior art keywords
sample
fraction
concentration
whole
hemolysis
Prior art date
Application number
PCT/US1994/010588
Other languages
French (fr)
Other versions
WO1995010044A1 (en
Filing date
Publication date
Priority claimed from US08/131,527 external-priority patent/US5416026A/en
Application filed filed Critical
Priority to EP94929841A priority Critical patent/EP0722569B1/en
Priority to KR1019960701796A priority patent/KR100247327B1/en
Priority to DE69432122T priority patent/DE69432122T2/en
Priority to AU78758/94A priority patent/AU696428B2/en
Priority to CA002173461A priority patent/CA2173461A1/en
Priority to AT94929841T priority patent/ATE232606T1/en
Priority to JP51082395A priority patent/JP3527741B2/en
Publication of WO1995010044A1 publication Critical patent/WO1995010044A1/en
Publication of WO1995010044B1 publication Critical patent/WO1995010044B1/en

Links

Abstract

The present invention concerns a method of detecting hemolysis in a whole-blood sample, a method of determining an elevation in the potassium ion concentration of a whole-blood sample, an apparatus for detecting hemolysis and/or determining an elevation in the potassium ion concentration in a fluid sample, an apparatus for detecting hemolysis and/or determining an elevation in the potassium ion concentration in a whole-blood sample, and a single-use cartridge containing a plurality of microfabricated biosensors which further contains a hemolysis detection unit.

Claims

AMENDED CLAIMS[received by the International Bureau on 24 March 1995 (24.03.95); original claims 1, 13, 14, 18, 22, 25 and 37 amended; new claims 39-46 added; remaining claims unchanged (8 pages)]
1. A method of detecting hemolysis in a whole-blood sample comprising:
(a) contacting a whole-blood sample comprising intact red blood cells with a dry separation material having a site where said whole blood sample is introduced and a remainder, said material having physical characteristics effective to separate by wicking action a fraction, which contains extracellular hemoglobin that may be present in said sample, from the intact red blood cells;
(b) allowing said sample to remain in contact with said material for a period of time sufficient to effect said separation; and
(c) detecting at a location in said remainder the presence of extracellular hemoglobin in said fraction.
2. The method of claim 1 in which said fraction includes plasma.
3. The method of claim 1 in which said detecting step comprises visually inspecting said fraction for the presence of a color hue.
4. The method of claim 3 which further comprises comparing said color hue to a colored chart displaying a variety of color hues, each of said color hues indicative of an estimated concentration of extracellular hemoglobin present in a given separated fraction.
5. The method of claim 4 in which the estimated concentration of extracellular hemoglobin is at least 2 mg/dL.
6. The method of claim 4 in which the estimated concentration of extracellular hemoglobin is at least 20 mg/dL.
7. The method of claim 1 in which said detecting step comprises contacting said fraction with a chromogenic reager.; .
8. The method oi claim 7 in which said fraction contains hemoglobin, and said hemoglobin reacts with said chromogenic reagent to provide a visually detectable color change.
9. The method of claim 8 in which said chromogenic reagent is selected from the group consisting of o-toluidine, diisopropylbenzene dihydroperoxide and tetramethylbenzidine.
10. The method of claim 1 in which said detecting step is performed with the aid of a reflectance meter, said meter providing a reading that is a function of the concentration of extracellular hemoglobin present in said fraction.
11. The method of claim 1 or 10 which further comprises estimating the elevation of an analyte in said sample which is due to the hemolysis of red blood cells.
12. The method of claim 2 or 10 which specifically detects a level of hemolysis sufficient to cause an elevation of the potassium concentration by at least 0.1 mM above the potassium concentration which would otherwise have been present in the plasma fraction had the whole-blood sample been free from hemolysis.
13. The method of Claim 1, wherein said analyte is selected from the group consisting of potassium ion, lactate dehydrogenase, and acid phosphatase.
14. The method of claim 1 which further comprises adjusting the apparent concentration or activity of said analyte to account for the proportion of same which is due to the hemolysis of red blood cells.
15. The method of claim 1 in which the physical characteristics of said dry separation material include dimensions in length of from 5 to 50 mm, in width of from 1 to 10 mm, and in thickness of from 0.1 to 3.0 mm.
16. The method of claim 2 in which said fraction is separated from said intact red blood cells by a wicking action of said dry separation material, wherein said red blood cells are retarded relative to the separated fraction.
17. The method of claim 1 in which said dry separation material comprises a composite medium of glass fibers, cellulose fibers and synthetic textile fibers.
18. A method of determining the elevation in the potassium ion concentration due to hemolysis of intact red blood cells in a whole-blood sample, comprising:
(a) contacting a whole-blood sample comprising intact red blood cells with a dry separation material having a site where said whole blood sample is introduced and a remainder, said material having physical characteristics effective to separate by wicking action a plasma fraction, which contains extracellular hemoglobin that may be present in said sample, from the intact red blood cells;
(b) allowing said sample to remain in contact with said material for a period of time sufficient to effect said separation;
(c) estimating the quantity of extracellular hemoglobin in said plasma fraction at a location in said remainder; and
(d) estimating the elevation of the potassium ion concentration in said sample which is due to hemolysis.
19. The method of claim 1 or 18 which is performed in a single-use whole-blood analysis cartridge which comprises said dry separation material and an ion-selective electrode for measuring the concentration of potassium ion.
20. The method of claim 19 in which said potassium ion- selective is microfabricated on a silicon chip.
21. The method of Claim 15, further comprising comparing said elevation of the potassium ion concentration to a pre¬ selected value of hemolysis, and rejecting as unreliable for clinical purposes an elevation above said pre-selected value.
22. An apparatus for detecting hemolysis in a fluid sample comprising:
(a) a dry separation material having a site to which said fluid sample is applied and a remainder, said material having physical characteristics effective to separate by wicking action a fraction of said sample, which fraction would contain a representative concentration of any extracellular hemoglobin that may be present in said sample; and
(b) a detection means for ascertaining at a location in said remainder the concentration of said extracellular hemoglobin in said fraction.
23. The apparatus of claim 22 in which said fluid sample is whole-blood.
24. The apparatus of claim 22 in which said fluid sample is urine.
25. An apparatus f r detecting hemolysis in a who .-blood sample having intact red blood cells comprising:
(a) a dry separation material having a site where said whole blood sample is applied and a remainder, said material having physical characteristics effective to separate by wicking action a fraction of said sample, which fraction would contain a representative concentration of any extracellular hemoglobin that may be present in said sample, from the intact red blood cells; and
(b) a detection means for ascertaining at a location in said remainder the presence of extracellular hemoglobin in said fraction.
26. The apparatus of claim 22 or 25 in which said detection means comprises a colored chart displaying at least one color hue of an estimated concentration of extracellular hemoglobin present in a given separated fraction.
27. The apparatus of claim 22 or 25 in which said detection means comprises a chromogenic reagent that reacts with said extracellular hemoglobin to provide a color change.
28. The apparatus of claim 22 or 25 in which said detection means is contained in a viewing region that comes into contact with said fraction.
29. The apparatus of claim 27 which further comprises an orifice for introduction of said sample.
30. The apparatus of claim 22 or 25 which is a single- use cartridge.
31. The apparatus of claim 25 in which said sample is separated into a plasma fraction that can be observed through a viewing window, said window substantially excluding from view that portion of the separated sample which contains the intact red blood cells.
32. The apparatus of claim 31 in which a colored chart is positioned within view of said window, said colored chart displaying at least one color hue indicative of an estimated concentration of extracellular hemoglobin present in a given plasma fraction.
33. The apparatus of claim 32 in which said color hue correlates to an elevation in the potassium concentration in said plasma fraction by at least 0.1 millimole per liter.
34. The apparatus of claim 32 in which said color hue correlates to an elevation in the potassium concentration in said plasma fraction by at least 0.5 millimole per liter.
35. The apparatus of Claim 22 or 32, comprising at least two color hues, each of which is indicative of an estimated concentration of extra cellular hemoglobin present in a given plasma fraction.
36. The apparatus of claim 21 in which said detection means comprises a reflectance meter including a light source and a light detector, said light source being positioned to permit an incident light beam from said light source to strike said fraction to provide a reflected light beam and said light detector being positioned to permit detection of said reflected light beam.
37. A single-use cartridge, comprising a plurality of microfabricated biosensors arranged to determine the presence or concentration of one or more physiological analytes in a whole-blood sample, said assembly further comprising a hemolysis detection unit comprising:
(a) a dry separation material having a site where said whole blood sample is applied and a remainder, said material physical characteristics effective to separate by wicking action a fraction of said sample, which fraction would contain a representative concentration of any extracellular hemoglobin that may be present in said sample; and (b) a detection means for ascertaining at a location in said remainder the concentration of said extracellular hemoglobin in said fraction.
38. The single-use cartridge of claim 37 which includes a microfabricated potassium ion selective electrode and reference electrode, used to determine the concentration of potassium ion in said sample.
39. A method of estimating a change in an analyte in a whole-blood sample which is due to the hemolysis of red blood cells, comprising:
(a) contacting a whole-blood sample comprising intact red blood cells with a dry separation material having a site where said whole blood sample is introduced and a remainder, said material having physical characteristics effective to separate by wicking action a fraction, which contains extracellular hemoglobin that may be present in said sample, from the intact red blood cells;
(b) allowing said sample to remain in contact with said material for a period of time sufficient to effect said separation;
(c) detecting at a location in said remainder the presence of extracellular hemoglobin in said fraction; and
(d) estimating the change in said analyte in said sample which is due to the hemolysis of red blood cells.
40. The method of Claim 39, wherein said change is an elevation.
41. The method of Claim 39, wherein said change is in the concentration or activity of said analyte.
42. The method of Claim 18 or 39, further comprising the step of determining the presence, concentration or activity of one or more additional physiological analytes in said whole blood sample.
43. The method of Claim 41, wherein said determining comprises contacting said whole blood sample with a plurality of microfabricated biosensors.
44. The method of Claim 43, wherein said additional physiological analyte is potassium.
45. The method of Claim 1, 18 or 39, wherein said dry separation material has an outermost edge and a dimensional axis defined by said site where said whole blood sample is introduced and said outermost edge, and said location in said remainder where said detecting occurs is between said outermost edge and a point one-third of the distance along said dimensional axis.
46. The method of Claim 1, 18 or 39, wherein said dry separation material does not cause visible hemolysis of said intact red blood cells.
PCT/US1994/010588 1993-10-04 1994-09-28 A method and apparatus for detecting hemolysis in a fluid sample WO1995010044A1 (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
EP94929841A EP0722569B1 (en) 1993-10-04 1994-09-28 A method and apparatus for detecting hemolysis in a fluid sample
KR1019960701796A KR100247327B1 (en) 1993-10-04 1994-09-28 Method and apparatus for detecting hemolysis in a fluid sample
DE69432122T DE69432122T2 (en) 1993-10-04 1994-09-28 METHOD AND DEVICE FOR DETECTING HEMOLYSIS IN LIQUID SAMPLES
AU78758/94A AU696428B2 (en) 1993-10-04 1994-09-28 A method and apparatus for detecting hemolysis in a fluid sample
CA002173461A CA2173461A1 (en) 1993-10-04 1994-09-28 A method and apparatus for detecting hemolysis in a fluid sample
AT94929841T ATE232606T1 (en) 1993-10-04 1994-09-28 METHOD AND DEVICE FOR DETECTING HEMOLYSIS IN LIQUID SAMPLES
JP51082395A JP3527741B2 (en) 1993-10-04 1994-09-28 Method and apparatus for detecting hemolysis in a body fluid sample

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/131,527 US5416026A (en) 1993-10-04 1993-10-04 Method for detecting the change in an analyte due to hemolysis in a fluid sample
US131,527 1993-10-04

Publications (2)

Publication Number Publication Date
WO1995010044A1 WO1995010044A1 (en) 1995-04-13
WO1995010044B1 true WO1995010044B1 (en) 1995-04-27

Family

ID=22449838

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1994/010588 WO1995010044A1 (en) 1993-10-04 1994-09-28 A method and apparatus for detecting hemolysis in a fluid sample

Country Status (10)

Country Link
US (2) US5416026A (en)
EP (1) EP0722569B1 (en)
JP (1) JP3527741B2 (en)
KR (1) KR100247327B1 (en)
CN (1) CN1135260A (en)
AT (1) ATE232606T1 (en)
AU (1) AU696428B2 (en)
CA (1) CA2173461A1 (en)
DE (1) DE69432122T2 (en)
WO (1) WO1995010044A1 (en)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4427492A1 (en) * 1994-08-03 1996-02-08 Boehringer Mannheim Gmbh Method for analyzing a medical sample while avoiding interference from hemolysis
EP0805981A1 (en) * 1995-01-25 1997-11-12 Therakos, Inc. Disposable hemolysis detector
FR2733835B1 (en) * 1995-05-03 1997-07-18 Hycel Groupe Lisabio METHOD AND DEVICE FOR DETECTING THE LYSIS POINT OF RED CELLS
CA2221364A1 (en) * 1995-05-18 1996-11-21 Aura Communications, Inc. Short-range magnetic communication system
US7198955B1 (en) * 1997-03-03 2007-04-03 Nir Diagnostics Inc. Method and apparatus for measurement of blood substitutes
US6177283B1 (en) * 1997-05-28 2001-01-23 Flexsite Diagnostics, Inc. Diagnostic assay
US6002475A (en) * 1998-01-28 1999-12-14 Careside, Inc. Spectrophotometric analytical cartridge
US5919711A (en) * 1997-08-07 1999-07-06 Careside, Inc. Analytical cartridge
US5916522A (en) * 1997-08-07 1999-06-29 Careside, Inc. Electrochemical analytical cartridge
CA2318127A1 (en) 1998-01-20 1999-07-22 University Of Victoria Innovation And Development Corporation Detection of gpi anchored proteins
US6348176B1 (en) 1999-02-11 2002-02-19 Careside, Inc. Cartridge-based analytical instrument using centrifugal force/pressure for metering/transport of fluids
US6391264B2 (en) 1999-02-11 2002-05-21 Careside, Inc. Cartridge-based analytical instrument with rotor balance and cartridge lock/eject system
US6531095B2 (en) 1999-02-11 2003-03-11 Careside, Inc. Cartridge-based analytical instrument with optical detector
US6623972B2 (en) * 2000-06-09 2003-09-23 Bayer Corporation Automated method for detecting, quantifying and monitoring exogenous hemoglobin in whole blood, plasma and serum
US7214300B2 (en) * 2001-06-04 2007-05-08 Epocal Inc. Integrated electrokinetic devices and methods of manufacture
US6896778B2 (en) * 2001-06-04 2005-05-24 Epocal Inc. Electrode module
US6797236B2 (en) * 2002-01-14 2004-09-28 Infineon Technologies Ag Design and signal recovery of biomolecular sensor arrays
US10022078B2 (en) 2004-07-13 2018-07-17 Dexcom, Inc. Analyte sensor
US20040018577A1 (en) 2002-07-29 2004-01-29 Emerson Campbell John Lewis Multiple hybrid immunoassay
US7767068B2 (en) * 2002-12-02 2010-08-03 Epocal Inc. Heterogeneous membrane electrodes
US7842234B2 (en) 2002-12-02 2010-11-30 Epocal Inc. Diagnostic devices incorporating fluidics and methods of manufacture
US7261861B2 (en) * 2003-04-24 2007-08-28 Haemoscope Corporation Hemostasis analyzer and method
US7920906B2 (en) 2005-03-10 2011-04-05 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US7722817B2 (en) * 2003-08-28 2010-05-25 Epocal Inc. Lateral flow diagnostic devices with instrument controlled fluidics
US9247900B2 (en) 2004-07-13 2016-02-02 Dexcom, Inc. Analyte sensor
US7946984B2 (en) 2004-07-13 2011-05-24 Dexcom, Inc. Transcutaneous analyte sensor
GB0503836D0 (en) * 2005-02-24 2005-04-06 Axis Shield Asa Method
US7879615B2 (en) * 2005-10-20 2011-02-01 Coramed Technologies, Llc Hemostasis analyzer and method
CA2641864C (en) 2006-02-08 2016-05-10 Becton, Dickinson And Company Improved label processor and method relating thereto
US7790464B2 (en) * 2006-05-04 2010-09-07 Blaze Medical Devices, LLC Blood hemolysis analyzer
CA2649633C (en) * 2006-06-06 2012-11-27 F. Hoffmann-La Roche Ag Differential hemolysis of a whole blood sample
SE530596C2 (en) * 2006-10-13 2008-07-15 Mathias Karlsson Method of determining oxygen deficiency in blood from the scalp during labor
JP5419993B2 (en) * 2008-12-31 2014-02-19 アボット ポイント オブ ケア インコーポレイテッド Method and apparatus for immunoassay using nucleotide conjugates
US8084223B2 (en) * 2009-03-23 2011-12-27 Siemens Healthcare Diagnostics Inc. Detection of false results in assays
US20110001103A1 (en) * 2009-07-01 2011-01-06 Chi-Kuang Chen Elevating mechanism for measuring concentrations of medicines
US8973293B2 (en) 2010-11-19 2015-03-10 Becton, Dickinson And Company Specimen container label for automated clinical laboratory processing systems
WO2012075258A2 (en) 2010-12-03 2012-06-07 Abbott Point Of Care Inc. Ratiometric immunoassay method and blood testing device
US9050595B2 (en) 2010-12-03 2015-06-09 Abbott Point Of Care Inc. Assay devices with integrated sample dilution and dilution verification and methods of using same
CA2819195A1 (en) 2010-12-03 2012-06-07 Abbott Point Of Care Inc. Sample metering device and assay device with integrated sample dilution
EP2646153B1 (en) 2010-12-03 2019-05-01 Abbott Point of Care Inc. Sample metering device and assay device with integrated sample dilution
WO2012111328A1 (en) * 2011-02-15 2012-08-23 Matumura Takahito Urine test sheet
WO2013027611A1 (en) * 2011-08-24 2013-02-28 栄研化学株式会社 Leukocyte measurement device and reagent kit
US9625465B2 (en) 2012-05-15 2017-04-18 Defined Diagnostics, Llc Clinical diagnostic systems
US9213043B2 (en) 2012-05-15 2015-12-15 Wellstat Diagnostics, Llc Clinical diagnostic system including instrument and cartridge
US9075042B2 (en) 2012-05-15 2015-07-07 Wellstat Diagnostics, Llc Diagnostic systems and cartridges
US9658181B2 (en) * 2013-03-14 2017-05-23 Instrumentation Laboratory Company Whole blood hemolysis sensor
JP6166938B2 (en) * 2013-04-18 2017-07-19 ローム株式会社 Microchip
CN104655596A (en) * 2013-11-18 2015-05-27 李捷 Quality test method of blood sample containing erythrocyte, and test kit
MX2016016266A (en) * 2014-06-13 2017-07-05 Siemens Healthcare Diagnostics Inc Detection of hemolysis using a chromatographic detection pad.
EP3201624B1 (en) * 2014-09-30 2020-03-11 Siemens Healthcare Diagnostics Inc. Hemolysis detection device, system and method
US9547899B1 (en) * 2014-10-07 2017-01-17 University Of South Florida Mobile hemolysis detection in whole blood samples
EP3234570B1 (en) * 2014-12-19 2022-08-31 Siemens Healthcare Diagnostics Inc. Hemolysis detection using intracellular analyte concentrations
ES2925018T3 (en) 2016-05-11 2022-10-13 Nova Biomedical Corp Whole blood SO2 sensor
US20210148888A1 (en) * 2017-08-09 2021-05-20 Joanneum Research Forschungsgesellschaft Mbh Accurate Sensing of Physiological Substance in Blood
CN111000566B (en) * 2019-12-13 2021-05-11 江南大学 Wearable flexible sensor with photothermal effect and antibacterial function
WO2024016077A1 (en) * 2022-07-19 2024-01-25 Hylid Diagnostics Inc. Point-of-care blood analysis system
GB2620968A (en) * 2022-07-28 2024-01-31 Kalium Health Ltd Sensor, apparatus, kit and method
CN116298328A (en) * 2022-12-06 2023-06-23 北京大学第三医院(北京大学第三临床医学院) Kit for determining blood potassium concentration of hemolysis specimen

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3552925A (en) * 1967-07-13 1971-01-05 Miles Lab Whole blood separation method and test using same
US3539300A (en) * 1967-10-23 1970-11-10 Schering Corp Body fluid collector and separator having improved flow rate
US3972614A (en) * 1974-07-10 1976-08-03 Radiometer A/S Method and apparatus for measuring one or more constituents of a blood sample
US4057394A (en) * 1976-05-24 1977-11-08 Miles Laboratories, Inc. Test device and method for determining blood hemoglobin
DE2847176C2 (en) * 1977-10-31 1982-05-06 Hitachi, Ltd., Tokyo Method for the photometric determination of substances in blood serum
US4816224A (en) * 1980-08-05 1989-03-28 Boehringer Mannheim Gmbh Device for separating plasma or serum from whole blood and analyzing the same
DE3029579C2 (en) * 1980-08-05 1985-12-12 Boehringer Mannheim Gmbh, 6800 Mannheim Method and means for separating plasma or serum from whole blood
JPS6052761A (en) * 1983-09-01 1985-03-26 Olympus Optical Co Ltd Measuring method for electrolyte
US4696797A (en) * 1985-04-15 1987-09-29 Environmental Diagnostics, Inc. Suspension liquid separator
EP0230645A3 (en) * 1985-12-28 1987-12-09 Fuji Photo Film Co., Ltd. Ionic activity measuring device
US4761369A (en) * 1986-05-12 1988-08-02 David Diagnostics, Inc. Process for measuring calcium levels in biological fluids
JPS6350743A (en) * 1986-08-20 1988-03-03 Hitachi Ltd Analysis of hemolyzed blood specimen
US4753776A (en) * 1986-10-29 1988-06-28 Biotrack, Inc. Blood separation device comprising a filter and a capillary flow pathway exiting the filter
US5096669A (en) * 1988-09-15 1992-03-17 I-Stat Corporation Disposable sensing device for real time fluid analysis
DE4015589A1 (en) * 1990-05-15 1991-11-21 Boehringer Mannheim Gmbh DEVICE AND THE USE THEREOF FOR SEPARATING PLASMA FROM WHOLE BLOOD
US5186843A (en) * 1991-07-22 1993-02-16 Ahlstrom Filtration, Inc. Blood separation media and method for separating plasma from whole blood
US5223219A (en) * 1992-04-10 1993-06-29 Biotrack, Inc. Analytical cartridge and system for detecting analytes in liquid samples

Similar Documents

Publication Publication Date Title
WO1995010044B1 (en) A method and apparatus for detecting hemolysis in a fluid sample
US5593638A (en) Apparatus for estimating the change in an analyte from hemolysis in a fluid sample
US7758744B2 (en) Dual glucose-turbidimetric analytical sensors
Hoffmann Multicentre evaluation of an enzymatic method for creatinine determination using a sensitive colour reagent
EP2733217B1 (en) Method for detection of humidity-compromised urine test strips
EP0071934B1 (en) Method for preparing a color stable chromogenic analytical element
US4350762A (en) Aminopyrine improved Trinder's reagent and dosing process for hydrogen peroxide from enzymatic oxidation of metabolic substrata with the same
EP1281960A2 (en) Methods and devices for use in analyte concentration determination assays
EP0816849A2 (en) Method for the determination of analytes
US20040265941A1 (en) Combined assay for current glucose level and intermediate or long-term glycemic control
JPH10505675A (en) Optically readable strip for analyte detection with on-strip orientation index
EP0371513B1 (en) Device and method for assay of liquid sample
EP0349843A2 (en) Composition and method of assaying aqueous liquids for specific gravity
CN104714040B (en) Glucose in serum oxidase double reagent assay method
JPH0695954B2 (en) Creatinine or creatine measuring element and measuring method
Bissbort et al. Novel test and its automation for the determination of erythrocyte acetylcholinesterase and its application to organophosphate exposure
Gillard Quantitative gel-electrophoretic determination of serum amylase isoenzyme distributions.
US20090148872A1 (en) Lipoprotein sensor
EP0258034B1 (en) Analytical element and method for theophylline determination using buffer in spreading zone
EP0533283B1 (en) Assay for serum cholinesterase acitivity
Delahunty et al. Automated creatine kinase-MB estimation by immuno-inhibition: a clinical evaluation.
EP0258035B1 (en) Analytical element and method for theophylline determination having increased alkaline phosphatase isoenzyme
US20100297601A1 (en) Small volume and ultra speed colorimetric sensor
WO1998000703A1 (en) Test strip including integral specimen flow retarding structure
US5268269A (en) Scleroprotein and scleroprotein hydrolysate containing agent for detection of cholesterol